Article

Development and characterization of neutralizing antibodies against SRAS-CoV-2

2022-07-19

Abstract excerpt

<h4>Background: </h4> The novel coronavirus disease 2019(COVID-19) caused by SARS-CoV-2 that belongs to betacoronaviruseis, and is an enveloped, single and positive-stranded RNA virus. In this study, we describe the production and characterization of four monoclonal antibodies (mAb) with neutralization activities. Methods Thirteen mAbs that identified positive were characterized by neutralization assays, binding...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ae0f92a7-c4db-5a43-99da-1af6e0ee985c
DOI: 10.21203/rs.3.rs-1840948/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and characterization of neutralizing antibodies against SRAS-CoV-2DOI 10.21203/rs.3.rs-1840948/v1Read

An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodiesSemantic proximity Read

Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopesSemantic proximity Read

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsSemantic proximity Read

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies.Semantic proximity Read

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational lockingSemantic proximity Read

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesSemantic proximity Read

Generation and characterization of a multi-functional panel of monoclonal antibodies for SARS-CoV-2 research and treatmentSemantic proximity Read

Neutralizing antibodies targeting SARS-CoV-2 spike proteinSemantic proximity Read

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.Semantic proximity Read

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesSemantic proximity Read

Structural and mutational analyses define distinct molecular routes to broad SARS-CoV-2 receptor-binding domain recognitionSemantic proximity Read